drugset / Trial / NCT04786223

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

NCT04786223 ↗

Phase 2 Enrolling by invitation 125 enrolled Val Lowe
NaSingle-groupOpen-labelDiagnostic

Summary

This study is being done to research the usefulness of PET/CT imaging for measuring brain inflammation and its relation to Alzheimer's Disease Dementia and related dementias. Additionally, researchers are looking to learn more about the side effects of a new radioactive tracer (radiotracer) C-11 ER176.

Timeline

Start
2021-03-30
Primary completion
2029-03
Completion
2030-03

Drugs

EvaluationDrugModalityDoseRoute
Subject C-11 ER176 Unknown — Intravenous